Research and trials

• Science & Technology

A new target to slow down ageing and reduce blood cancer risk

New research has shown that a molecule called formaldehyde causes DNA damage to blood stem cells, which can accelerate their ageing and increase the likelihood of blood cancers. New research has shown that a molecule called formaldehyde causes DNA damage to blood stem cells, which can accelerate their ageing and increase the likelihood of blood cancers.

29 June 2023

• Charity News
• Health & Medicine

Research project launched in memory of Sarah Harding recruits first participant

A new breast cancer research project, launched in memory of Girls Aloud singer Sarah Harding, has recruited its first participant. A new breast cancer research project, launched in memory of Girls Aloud singer Sarah Harding, has recruited its first participant.

27 June 2023

• For Researchers

A new culture – how CRUK is helping to take organoids global

Cancer patient-derived organoids from Japan’s Fukushima Medical University have become the latest technology to be made available via CancerTools.org Cancer patient-derived organoids from Japan’s Fukushima Medical University have become the latest technology to be made available via CancerTools.org

19 June 2023

• Science & Technology

Wasting syndrome: What is cachexia?

Cachexia is a complex syndrome which has puzzled researchers for decades. But with new research from Cancer Grand Challenges, we could be close to uncovering its mysteries. Cachexia is a complex syndrome which has puzzled researchers for decades. But with new research from Cancer Grand Challenges, we could be close to uncovering its mysteries.

19 June 2023

• Health & Medicine
• Science & Technology

ASCO 2023 roundup: Blood tests, drugs and exercise

ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients. ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients.

12 June 2023

• For Researchers

Harnessing the power of CD3

Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out... Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out...

30 May 2023

• Health & Medicine

Age: the forgotten cancer risk factor?

Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight.  Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight. 

29 May 2023

• Science & Technology

How MRI add-ons could accelerate the development of new treatments

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

9 May 2023

• Health & Medicine

Severe mental illness linked to low attendance at cancer screening

New research has found that adults with severe mental illness are less likely to attend cancer screening than those who do not have such conditions. New research has found that adults with severe mental illness are less likely to attend cancer screening than those who do not have such conditions.

4 May 2023

• Health & Medicine

FOCUS4: Learning from a landmark clinical trial

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

25 April 2023

• Science & Technology
• Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

18 April 2023